Phibro Animal Health (PAHC) Amortizatization of Intangibles (2015 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Amortizatization of Intangibles of $1.7 million in Q1 2026, up 0.53% quarter-over-quarter from $1.7 million in Q4 2025, and little changed on a YoY basis from $1.7 million in Q1 2025.
Phibro Animal Health (PAHC) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends
Phibro Animal Health's Amortizatization of Intangibles history runs 12 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles changed 0.17% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $6.8 million (down 19.21% YoY), while the FY2025 annual figure was $7.8 million, down 18.82% from the prior year.
- Amortizatization of Intangibles was $1.7 million for Q1 2026 at Phibro Animal Health, up from $1.7 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.5 million in Q4 2023 to a low of $1.7 million in Q2 2025.
- Historically, Amortizatization of Intangibles has averaged $2.2 million across 5 years, with a median of $2.3 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Amortizatization of Intangibles grew 14.18% in 2022, then dropped 29.14% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $2.4 million in 2022, then advanced by 1.35% to $2.5 million in 2023, then slipped by 12.45% to $2.2 million in 2024, then decreased by 20.88% to $1.7 million in 2025, then increased by 0.53% to $1.7 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $1.7 million (Q1 2026), $1.7 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Phibro Animal Health | 1.26 Bn | 1.19 Bn | 125.68 Mn | 1.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.72 Mn |
| Mar 31, 2026 | 1.72 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.70 Mn |
| Jun 30, 2025 | 1.70 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Dec 31, 2024 | 2.17 Mn |
| Dec 31, 2024 | 2.17 Mn |
| Sep 30, 2024 | 2.26 Mn |
| Sep 30, 2024 | 2.26 Mn |
| Jun 30, 2024 | 2.32 Mn |
| Jun 30, 2024 | 2.32 Mn |
| Mar 31, 2024 | 2.43 Mn |
| Mar 31, 2024 | 2.43 Mn |
| Dec 31, 2023 | 2.47 Mn |
| Dec 31, 2023 | 2.47 Mn |